Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB26FA13R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,340
Award facts
- Contract value 100% obligated
- $63,340.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $63.3K delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) vials on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order, which is not set-aside, leverages AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1B global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen is headquartered in Conshohocken, Pennsylvania, and serves as a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including military and veteran programs.
The delivery order supports DLA's medical supply chain operations by sourcing diabetes medication from AmerisourceBergen, a primary vendor capable of meeting federal procurement requirements through competitive award mechanisms. As a child contract under the SPE2DX master vehicle, this order exemplifies the type of individual pharmaceutical deliveries executed under the larger IDC framework, which enables AmerisourceBergen to supply a comprehensive range of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and one-day completion window reflect the time-sensitive nature of pharmaceutical procurement within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FA13R?
SPE2DB26FA13R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FA13R worth?
The government has obligated $63,340 on SPE2DB26FA13R.
Is contract SPE2DB26FA13R an order under another contract?
Yes. SPE2DB26FA13R is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA13R competed?
The extent of competition for SPE2DB26FA13R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award